The Clinton administration outlined the FDA's role in the nation's plan to ramp up its responses to terrorism and unconventional war. Speaking at a two-day National Symposium on Medical and Public Health Responses to Bioterrorism last week, CBER Director Kathryn Zoon said her agency will "assist in the identification of facilities that may be